Wealthcare Advisory Partners’s Spyre Therapeutics SYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-80	Closed	-$21K	–	1302
2018 Q2	$21K	Buy	+80	New	+$21K	﹤0.01%	663